Researchers says hydroxychloroquine could still prevent COVID-19
Pharma Times
AUGUST 7, 2020
Scientists from the University of Oxford say the drug is being ‘discarded prematurely’
Pharma Times
AUGUST 7, 2020
Scientists from the University of Oxford say the drug is being ‘discarded prematurely’
NY Times
AUGUST 6, 2020
A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel when reviewing data on coronavirus trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 4, 2020
New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. Several factors make it difficult for HTA bodies often to assess orphan drugs, including a lack of robust trial data due to difficulties in finding patients, the absence of randomised controlled tri
Outsourcing Pharma
AUGUST 5, 2020
The firms are working to create a platform that gives the ability to monitor temperature-sensitive treatments, vaccines and other products.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharma Times
AUGUST 4, 2020
New deal with Wockhardt boosts capacity at the crucial 'fill and finish' stage
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
AUGUST 7, 2020
Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is also being tested in combination with other drugs in an effort to fight the pandemic. Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.
Outsourcing Pharma
AUGUST 3, 2020
Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.
Pharma Times
AUGUST 5, 2020
Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings
Pharma Marketing Network
AUGUST 3, 2020
Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
AUGUST 5, 2020
The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year. In a letter , Steve Oldfield, chief commercial officer at the Department of Health and Social Care, said the government is focused on preventing potential disruption to any categories of medical supplies.
Outsourcing Pharma
AUGUST 5, 2020
The bipartisan bill calls for an assessment of the countryâs pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.
Pharma Times
AUGUST 4, 2020
Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour
NY Times
AUGUST 4, 2020
Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
AUGUST 4, 2020
Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca. The company’s shares were valued as high as 95p on the London Stock Exchange following the announcement, the highest they had been since 2015. AstraZeneca has bought an exclusive global licence to develop and market RXC006, a porcupine inhibitor for fibrotic diseases including idiopathic pulmonary fibrosis (IPF).
Outsourcing Pharma
AUGUST 6, 2020
A leader from the scientific software provider discusses the most challenging obstacles in the pharma supply chain, and solutions that can conquer them.
Pharma Times
AUGUST 3, 2020
Subcutaneous formulation of Darzalex in combination with pomalidomide and dexamethasone meets primary endpoint
Drug Patent Watch
AUGUST 4, 2020
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics from September 30th…. The post Finding and Evaluating Market Entry Opportunities for a Better ROI appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
AUGUST 7, 2020
Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Find out more in our roundup of the biggest R&D, market access and digital stories from the past week. The perception of pharma and medical companies has surged upward since the start of the COVID-19 pandemic, but they still lie mostly outside the top-rated firms in the FutureBrand Index.
Outsourcing Pharma
AUGUST 6, 2020
The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments.
Pharma Times
AUGUST 5, 2020
AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset
Drug Channels
AUGUST 7, 2020
Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy. Rob reviews how COVID-19 is changing patient access and adherence to specialty therapies. He then describes specific RxCrossroads’ program changes that are helping patients and providers remain on therapy and navigate this challenging environment. To learn more, visit www.McKesson.com/RxCrossroads.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
AUGUST 4, 2020
Sanofi has been placed under formal investigation in France for possible charges including manslaughter relating to the epilepsy drug Depakine, following the deaths of four babies whose mothers took the drug. Depakine was found to carry a high risk of birth defects if taken by pregnant women. Sanofi , which denies wrongdoing and says it warned of the risks long ago, is already being prosecuted in France following allegations it provided misleading information about the drug.
Outsourcing Pharma
AUGUST 6, 2020
A leader from IBM Watson Health talks about how its advanced EDC solution is geared toward helping studies save precious time and conserve costs.
Pharma Times
AUGUST 4, 2020
Agreement will utilise Oxford Biomedica's LentiVector platform
Pharmacy Joe
AUGUST 5, 2020
In this episode, I’ll discuss the dose of inhaled tranexamic acid used for nonmassive hemoptysis. Episode 528: What dose of inhaled tranexamic acid is used for nonmassive hemoptysis? Subscribe on iTunes , Android , or Stitcher Tranexamic acid (TA) is an antifibrinolytic medication. It forms a reversible complex that displaces plasminogen from fibrin resulting in inhibition of fibrinolysis.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Let's personalize your content